| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/26/2001 | WO2001029264A2 Nucleic acid primers and probes for detecting tumor cells |
| 04/26/2001 | WO2001029261A2 A method for high-density microarray mediated gene expression profiling |
| 04/26/2001 | WO2001029256A2 Cephalic pain susceptibility marker |
| 04/26/2001 | WO2001029255A2 Diagnostic test for cephalic pain |
| 04/26/2001 | WO2001029251A2 Improved mutation analysis of the nf1 gene |
| 04/26/2001 | WO2001029249A2 Conjoined polynucleotide catalysts |
| 04/26/2001 | WO2001029244A1 Nucleic acid transporter containing polypeptide and recombinant virus vector |
| 04/26/2001 | WO2001029243A1 Method and vector for producing and transferring trans-spliced peptides |
| 04/26/2001 | WO2001029242A2 Post-translational modification of recombinant proteins produced in plants |
| 04/26/2001 | WO2001029241A2 Methods and vectors for site-specific recombination in plant cell plastids |
| 04/26/2001 | WO2001029240A2 Regeneration |
| 04/26/2001 | WO2001029239A2 Modified resistance genes |
| 04/26/2001 | WO2001029238A2 Elongase promoters for the tissue-specific expression of transgenes in plants |
| 04/26/2001 | WO2001029237A2 Conditional sterility in wheat |
| 04/26/2001 | WO2001029236A1 Expression system for membrane proteins |
| 04/26/2001 | WO2001029234A2 Self-cleaving rna sequences and their use for the control of protein synthesis |
| 04/26/2001 | WO2001029233A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/26/2001 | WO2001029232A2 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage |
| 04/26/2001 | WO2001029231A2 Genetic switch |
| 04/26/2001 | WO2001029230A2 Engineering disease resistance with pectate lyase-like genes |
| 04/26/2001 | WO2001029229A1 Novel polypeptide, human retinoblastoma binding protein 20 and polynucleotide encoding it |
| 04/26/2001 | WO2001029228A1 A novel polypeptide, a human casein kinase 48 and the polynucleotide encoding the polypeptide |
| 04/26/2001 | WO2001029227A1 The beta-barrel of the lipid body lipoxygenase |
| 04/26/2001 | WO2001029226A2 Apoptosis inducing proteinaceous substance |
| 04/26/2001 | WO2001029225A1 A general method for optimizing the expression of heterologous proteins |
| 04/26/2001 | WO2001029224A2 Granulocyte peptide homolog zgpa1 |
| 04/26/2001 | WO2001029223A2 Type i membrane protein ztsl1 |
| 04/26/2001 | WO2001029222A2 Polypeptides having phospholipase b activity and nucleic acids encoding same |
| 04/26/2001 | WO2001029221A2 Proteins and polynucleotides encoding them |
| 04/26/2001 | WO2001029220A2 Mage-a12 antigenic peptides and uses thereof |
| 04/26/2001 | WO2001029219A1 Human cub-domain-containing protein and gene encoding the same |
| 04/26/2001 | WO2001029218A2 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 04/26/2001 | WO2001029217A2 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | WO2001029216A1 Sarcospan-deficient mouse as a model for clinical disorders associated with sarcospan mutations |
| 04/26/2001 | WO2001029215A2 N-cam homolog and splice variants thereof |
| 04/26/2001 | WO2001029214A1 Colon-tumour-associated antigens |
| 04/26/2001 | WO2001029213A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | WO2001029212A1 Methods for chimeragenesis of whole genomes or large polynucleotides |
| 04/26/2001 | WO2001029211A2 Method for directed evolution by random chimeragenesis on transient templates |
| 04/26/2001 | WO2001029210A1 A method for establishing connections between genes |
| 04/26/2001 | WO2001029209A1 Preparation of cellular components that are substantially free of chromosomal dna |
| 04/26/2001 | WO2001029208A1 Conditional gene trapping construct for the disruption of genes |
| 04/26/2001 | WO2001029207A1 Antiuracil monoclonal antibody |
| 04/26/2001 | WO2001029206A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/26/2001 | WO2001029205A2 Method for genetic manipulation |
| 04/26/2001 | WO2001029204A2 Protein production system |
| 04/26/2001 | WO2001029201A1 Expression of recombinant mature lysostaphin |
| 04/26/2001 | WO2001029200A1 DNA ENCODING ENDO-β-GALACTOSIDASE |
| 04/26/2001 | WO2001029199A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 04/26/2001 | WO2001029198A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 04/26/2001 | WO2001029197A2 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 04/26/2001 | WO2001029195A1 Polypeptides having glucanotransferase activity and nucleic acids encoding same |
| 04/26/2001 | WO2001029194A1 Porcine endogenous retrovirus (poerv) expressed in guinea pig and corresponding animal models |
| 04/26/2001 | WO2001029191A1 Method of in vitro culture of lymphocytes and gene therapy compositions |
| 04/26/2001 | WO2001029188A1 Geranyl diphosphate synthase large subunit, and methods of use |
| 04/26/2001 | WO2001029187A1 Process for producing microorganism-origin transglutaminase |
| 04/26/2001 | WO2001029185A1 Enzymatic production of difructose dianhydride iv from sucrose and relevant enzymes and genes coding for them |
| 04/26/2001 | WO2001029179A2 Regulation of gene expression by neuromodulators |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029175A2 Antisense modulation of fra-1 expression |
| 04/26/2001 | WO2001029129A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/26/2001 | WO2001029089A1 A RAT 7-TRANSMEMBRANE RECEPTOR, RATTUS rHNEAA81 |
| 04/26/2001 | WO2001029085A2 Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen v |
| 04/26/2001 | WO2001029084A2 Novel human proteins and polynucleotides encoding the same |
| 04/26/2001 | WO2001029083A1 POLYNUCLEOTIDES ENCODING HUMAN AND MURINE ADHESION PROTEINS (BIgR) |
| 04/26/2001 | WO2001029082A1 A DNA MOLECULE ENCODING A VARIANT α2B-ADRENOCEPTOR PROTEIN, AND USES THEREOF |
| 04/26/2001 | WO2001029080A1 A novel polypeptide - human high mobility group protein 13 and a polynucleotide encoding the same |
| 04/26/2001 | WO2001029079A1 IMMUNO-INTERACTIVE FRAGMENTS OF THE αC SUBUNIT OF INHIBIN |
| 04/26/2001 | WO2001029078A2 Method for production and use of mite group 1 proteins |
| 04/26/2001 | WO2001029074A1 Chimeric gene coding for a myb30 transcription factor and expression in plants |
| 04/26/2001 | WO2001029073A1 Methods for improving secondary metabolite production in fungi |
| 04/26/2001 | WO2001029072A2 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 04/26/2001 | WO2001029071A2 Genes associated with obesity and methods for using the same |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029068A2 A eag gene encoding for a potassium channel |
| 04/26/2001 | WO2001029063A2 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029059A1 Methods for analyzing the insertion capabilities of modified group ii introns |
| 04/26/2001 | WO2001029058A1 Rna interference pathway genes as tools for targeted genetic interference |
| 04/26/2001 | WO2001029057A1 Antisense modulation of bcl-6 expression |
| 04/26/2001 | WO2001029056A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | WO2001028684A2 System and method for filling a substrate with a liquid sample |
| 04/26/2001 | WO2001028683A1 Disposable test devices for performing nucleic acid amplification reactions |
| 04/26/2001 | WO2001028585A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 04/26/2001 | WO2001028580A2 Modulation of angiogenesis |
| 04/26/2001 | WO2001028569A1 Targeted vectors |
| 04/26/2001 | WO2001028321A1 Diabetes onset model mammal |
| 04/26/2001 | WO2001009335A3 Moraxella catarrhalis antigen basb120 |
| 04/26/2001 | WO2001005970A3 Gtp-binding protein associated factors |
| 04/26/2001 | WO2001005953A3 Maize ethylene signalling pathway ein3 genes and uses thereof |
| 04/26/2001 | WO2001005934A3 Feline calicivirus genes and vaccines, in particular recombined vaccines |
| 04/26/2001 | WO2000078958A3 Scorpion toxins from buthotus judaicus |
| 04/26/2001 | WO2000078444A3 Method and device for carrying out biochemical reactions with a high throughput |
| 04/26/2001 | WO2000077040A3 Human intracellular signaling molecules |
| 04/26/2001 | WO2000071723A3 Methods for regulating protein conformation using molecular chaperones |
| 04/26/2001 | WO2000070021A3 Differentiated human embryoid cells and a method for producing them |
| 04/26/2001 | WO2000068371A8 Method of cell cultivation |
| 04/26/2001 | WO2000066753A3 Modified vitamin k-dependent polypeptides |
| 04/26/2001 | WO2000066743A3 Viral expression vectors |
| 04/26/2001 | WO2000063369A3 Gene therapy |
| 04/26/2001 | WO2000061612A3 Compounds and methods for therapy and diagnosis of lung cancer |